Lung, D798AC00001 “eVOLVE-Lung02”

The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1L treatment in participants with mNSCLC in PD-L1 < 50%.

Advance Directives for New York State

Patient Newsletter 2024 June

Cancer Q&A with HOA: Cancer Survivorship

June is cancer survivor’s month, and this morning we were joined by medical oncologist and hematologist Dr. Iqra Choudary from Hematology-Oncology Associates’ Auburn office.

Talking With Children About Cancer

Patient Newsletter 2024 May

Patient Newsletter 2024 April

CBD Frequently Asked Questions

Patient Newsletter 2024 March

Free Colorectal Cancer Forum

SOLD OUT- HOA and Associated Gastroenterologists of CNY Offer Patient Education Forum

about Colorectal Cancer Prevention and Treatment on Tuesday, April 16 - SOLD OUT

Pages